JB Capital Partners LP Invests $3.54 Billion in Varex Imaging $VREX

JB Capital Partners LP acquired a new position in shares of Varex Imaging (NASDAQ:VREX) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 338,964 shares of the company’s stock, valued at approximately $3,535,395,000. Varex Imaging comprises approximately 0.5% of JB Capital Partners LP’s holdings, making the stock its 24th biggest position. JB Capital Partners LP owned 0.81% of Varex Imaging at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Rockefeller Capital Management L.P. acquired a new position in Varex Imaging during the fourth quarter worth about $27,000. Quarry LP acquired a new stake in shares of Varex Imaging in the 3rd quarter valued at approximately $64,000. BNP Paribas Financial Markets boosted its stake in shares of Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares in the last quarter. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging during the 3rd quarter valued at approximately $117,000. Finally, Cerity Partners LLC bought a new stake in shares of Varex Imaging during the 2nd quarter valued at approximately $123,000.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. CJS Securities downgraded shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 17th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Sidoti reiterated a “neutral” rating and set a $19.00 price target on shares of Varex Imaging in a report on Monday, August 10th. Oppenheimer cut Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. Finally, B. Riley Financial downgraded Varex Imaging from a “buy” rating to a “hold” rating in a report on Monday, August 10th. Six equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $16.88.

Varex Imaging Stock Up 0.1%

Shares of NASDAQ VREX opened at $18.51 on Friday. The company has a 50 day simple moving average of $12.38 and a 200 day simple moving average of $11.84. The firm has a market cap of $779.27 million, a PE ratio of 35.60 and a beta of 0.89. Varex Imaging has a 1 year low of $9.09 and a 1 year high of $18.63. The company has a debt-to-equity ratio of 0.64, a current ratio of 3.38 and a quick ratio of 1.53.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.21 by $0.10. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. The business had revenue of $210.50 million for the quarter, compared to the consensus estimate of $215.50 million. On average, research analysts forecast that Varex Imaging will post 0.98 EPS for the current year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.